CP
AGN

Corbenic Partners’s Allergan plc AGN Stock Holding History

Corbenic Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$18K – 205
2020
Q1 		$18K Sell
100
-15
-13% -$2.82K 0.01% 86
2019
Q4 		$22K Buy
+115
New +$20.7K 0.02% 96
2017
Q4 		$24K Sell
148
-50
-25% -$8.97K 0.03% 97
2017
Q3 		$41K Buy
198
+50
+34% +$11.6K 0.05% 73
2017
Q2 		$36K Hold
148
– – 0.05% 80
2017
Q1 		$35K Hold
148
– – 0.04% 85
2016
Q4 		$31K Buy
148
+15
+11% +$3.11K 0.03% 90
2016
Q3 		$31K Buy
+133
New +$32.5K 0.03% 88

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Corbenic Partners's AGN Position: Q2 2020 in Review

Corbenic Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 100 shares — an estimated $18K sold.

Corbenic Partners first reported a position in AGN in Q3 2016 and held it in 8 quarters. The position peaked at $41K in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Corbenic Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Corbenic Partners sold 100 Allergan plc shares in Q2 2020, an estimated $18K.
  • Corbenic Partners first reported a position in Allergan plc in Q3 2016 and held it in 8 quarters.
  • Corbenic Partners's Allergan plc position peaked at $41K in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Corbenic Partners's 13F filing for Q2 2020, filed 17 Jul 2020.